Candriam S.C.A.
Institutional investor · Portfolio as of Q3 2023
Top Holdings660 positions
Stock | Shares | Value | Weight | Avg Buy | Est. P&L | Held | Conviction |
|---|---|---|---|---|---|---|---|
TECK RESOURCES LTD-CLS B | 11,301 | $878.7M | 6.2% | $26.13 | +60.85% | 19 qtrssince 2019-Q1 | Decreased 0 |
MICROSOFT CORP | 2.3M | $723.3M | 5.1% | $177.01 | +75.40% | 19 qtrssince 2019-Q1 | Decreased 0 |
XP INC | 1.3M | $640.6M | 4.5% | $21.03 | +0.04% | 2 qtrssince 2023-Q2 | Increased 93 |
APPLE INC | 3.4M | $587.2M | 4.2% | $117.11 | +44.24% | 19 qtrssince 2019-Q1 | Decreased 0 |
ALPHABET INC-CL A | 3M | $386.7M | 2.7% | $95.45 | +36.07% | 19 qtrssince 2019-Q1 | Decreased 0 |
ZTO EXPRESS CAYMAN INC | 1.5M | $357.1M | 2.5% | $26.25 | -13.84% | 3 qtrssince 2023-Q1 | Increased 53 |
MERCK & CO. INC. | 3.3M | $343.4M | 2.4% | $71.01 | +35.04% | 19 qtrssince 2019-Q1 | Increased 57 |
NVIDIA CORP | 580,096 | $252.3M | 1.8% | $20.30 | +114.19% | 19 qtrssince 2019-Q1 | Increased 56 |
REGENERON PHARMACEUTICALS | 290,310 | $238.9M | 1.7% | $491.40 | +66.55% | 19 qtrssince 2019-Q1 | Decreased 0 |
AMGEN INC | 861,737 | $231.6M | 1.6% | $190.70 | +29.57% | 19 qtrssince 2019-Q1 | Increased 59 |
THERMO FISHER SCIENTIFIC INC | 457,412 | $231.5M | 1.6% | $417.16 | +20.50% | 19 qtrssince 2019-Q1 | Decreased 0 |
ELI LILLY & CO | 316,063 | $169.8M | 1.2% | $243.67 | +115.94% | 19 qtrssince 2019-Q1 | Decreased 0 |
PROCTER & GAMBLE CO/THE | 1.1M | $166.4M | 1.2% | $112.23 | +20.10% | 19 qtrssince 2019-Q1 | Increased 48 |
AMAZON.COM INC | 1.1M | $137.6M | 1.0% | $105.96 | +19.97% | 19 qtrssince 2019-Q1 | Decreased 0 |
DANAHER CORP | 615,393 | $135.4M | 1.0% | $175.77 | +23.54% | 19 qtrssince 2019-Q1 | Decreased 0 |
VERTEX PHARMACEUTICALS INC | 384,331 | $133.6M | 0.9% | $206.03 | +68.78% | 19 qtrssince 2019-Q1 | Decreased 0 |
ALPHABET INC-CL C | 965,173 | $127.3M | 0.9% | $96.54 | +35.56% | 19 qtrssince 2019-Q1 | Decreased 0 |
ADOBE INC | 248,520 | $126.7M | 0.9% | $413.03 | +23.45% | 19 qtrssince 2019-Q1 | Decreased 0 |
MASTERCARD INC - A | 309,488 | $122.5M | 0.9% | $290.13 | +34.50% | 19 qtrssince 2019-Q1 | Decreased 0 |
GILEAD SCIENCES INC | 1.5M | $113M | 0.8% | $51.46 | +34.89% | 19 qtrssince 2019-Q1 | Decreased 0 |
Candriam S.C.A. manages $14.1B across 660 positions as of Q3 2023. Top holdings: TECK (6.2%), MSFT (5.1%), XP (4.5%). Fund DNA: Steady Compounder. HoldingsIntel Rating: 2.5/5.0.
Active quarter - 0 new positions, 50 exits, 228 increased. Top move: XP (INCREASED, conviction 93). Portfolio: $14.1B across 660 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer